Nanopore Sequencing Enables Comprehensive Transposable Element Epigenomic Profiling.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
03 12 2020
Historique:
received: 29 06 2020
revised: 14 10 2020
accepted: 15 10 2020
pubmed: 14 11 2020
medline: 17 12 2020
entrez: 13 11 2020
Statut: ppublish

Résumé

Transposable elements (TEs) drive genome evolution and are a notable source of pathogenesis, including cancer. While CpG methylation regulates TE activity, the locus-specific methylation landscape of mobile human TEs has to date proven largely inaccessible. Here, we apply new computational tools and long-read nanopore sequencing to directly infer CpG methylation of novel and extant TE insertions in hippocampus, heart, and liver, as well as paired tumor and non-tumor liver. As opposed to an indiscriminate stochastic process, we find pronounced demethylation of young long interspersed element 1 (LINE-1) retrotransposons in cancer, often distinct to the adjacent genome and other TEs. SINE-VNTR-Alu (SVA) retrotransposons, including their internal tandem repeat-associated CpG island, are near-universally methylated. We encounter allele-specific TE methylation and demethylation of aberrantly expressed young LINE-1s in normal tissues. Finally, we recover the complete sequences of tumor-specific LINE-1 insertions and their retrotransposition hallmarks, demonstrating how long-read sequencing can simultaneously survey the epigenome and detect somatic TE mobilization.

Identifiants

pubmed: 33186547
pii: S1097-2765(20)30731-0
doi: 10.1016/j.molcel.2020.10.024
pii:
doi:

Substances chimiques

DNA Transposable Elements 0
DNA, Neoplasm 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

915-928.e5

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Auteurs

Adam D Ewing (AD)

Mater Research Institute, University of Queensland, Woolloongabba, QLD 4102, Australia. Electronic address: adam.ewing@mater.uq.edu.au.

Nathan Smits (N)

Mater Research Institute, University of Queensland, Woolloongabba, QLD 4102, Australia.

Francisco J Sanchez-Luque (FJ)

GENYO, Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research, PTS Granada 18016, Spain; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine (IGMM), University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK.

Jamila Faivre (J)

INSERM, U1193, Paul-Brousse University Hospital, Hepatobiliary Centre, Villejuif 94800, France.

Paul M Brennan (PM)

Translational Neurosurgery, Centre for Clinical Brain Sciences, Edinburgh EH16 4SB, UK.

Sandra R Richardson (SR)

Mater Research Institute, University of Queensland, Woolloongabba, QLD 4102, Australia.

Seth W Cheetham (SW)

Mater Research Institute, University of Queensland, Woolloongabba, QLD 4102, Australia. Electronic address: seth.cheetham@mater.uq.edu.au.

Geoffrey J Faulkner (GJ)

Mater Research Institute, University of Queensland, Woolloongabba, QLD 4102, Australia; Queensland Brain Institute, University of Queensland, St. Lucia, QLD 4067, Australia. Electronic address: faulknergj@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH